85 related articles for article (PubMed ID: 1937192)
1. [Sustained release verapamil in essential hypertension].
Yodfat Y; Nusbaum M; Gibor Y
Harefuah; 1991 May; 120(10):581-4. PubMed ID: 1937192
[TBL] [Abstract][Full Text] [Related]
2. [Controlled study on the treatment of hypertension with verapamil in retard form].
Belz GG; Spies G
Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562
[TBL] [Abstract][Full Text] [Related]
3. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil.
Houston MC; Weir M; Gray J; Ginsberg D; Szeto C; Kaihlenen PM; Sugimoto D; Runde M; Lefkowitz M
Arch Intern Med; 1995 May; 155(10):1049-54. PubMed ID: 7748048
[TBL] [Abstract][Full Text] [Related]
4. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
Weir MR; Cassidy CA; Hall PS; Lancaster A; Schubert C; Urick A; Saunders E; Kong BW; Jenkins P; Lavin PT
Clin Ther; 1990; 12(2):139-48. PubMed ID: 2354483
[TBL] [Abstract][Full Text] [Related]
7. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
8. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
Nifedipine-Atenolol Study Review Committee
Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
[TBL] [Abstract][Full Text] [Related]
9. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
10. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.
White WB; Johnson MF; Anders RJ; Elliott WJ; Black HR
Am Heart J; 2001 Dec; 142(6):1010-5. PubMed ID: 11717605
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schriger A
J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
[TBL] [Abstract][Full Text] [Related]
12. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
Frishman WH; Eisen G; Charlap S; Strom JA
J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517
[TBL] [Abstract][Full Text] [Related]
14. A new sustained-release formulation of verapamil in the treatment of hypertension.
Midtbo KA; Hals O; Lauve O
J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
[TBL] [Abstract][Full Text] [Related]
15. The combination of verapamil and captopril in the treatment of essential hypertension.
Heagerty AM; Swales JD
Pharmatherapeutica; 1987; 5(1):21-5. PubMed ID: 3299395
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive efficacy of sustained-release verapamil.
Zachariah PK; Sheps SG; Oshrain C; Schirger A; Stein WJ
J Clin Hypertens; 1987 Dec; 3(4):536-46. PubMed ID: 3330987
[TBL] [Abstract][Full Text] [Related]
19. [A comparison of the effects of verapamil and nifedipine on the quality of life].
Palmer A; Fletcher A; Hamilton G; Muriss S; Bulpitt C
Wien Med Wochenschr; 1991; 141(18-19):424-8. PubMed ID: 1776257
[TBL] [Abstract][Full Text] [Related]
20. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]